Merck veteran Perlmutter-led Eikon ‍Therapeutics valued at $860 million in Nasdaq debut - Reuters

Reuters | Feb. 5, 2026, 12:47 p.m. | Original
Merck veteran Perlmutter-led Eikon ‍Therapeutics valued at $860 million in Nasdaq debut Reuters
World Economic Forum investigates its CEO over Epstein links - TradingView Trump endorses Japan's Takaichi ahead of Sunday election - Reuters